- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 403/00 - Derivatives of cyclohexane or of a cyclohexene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene rings, e.g. vitamin A, beta-carotene, beta-ionone
Patent holdings for IPC class C07C 403/00
Total number of patents in this class: 33
10-year publication summary
|
5
|
4
|
1
|
1
|
0
|
1
|
1
|
0
|
1
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| DSM IP Assets B.V. | 5575 |
6 |
| BASF SE | 21039 |
2 |
| PTC Therapeutics, Inc. | 489 |
2 |
| Ramot at Tel-Aviv University Ltd. | 1490 |
2 |
| Glaxosmithkline LLC | 535 |
1 |
| Bayer Intellectual Property GmbH | 2487 |
1 |
| The United States of America as represented by the Secretary of the Navy | 2784 |
1 |
| Uop LLC | 4247 |
1 |
| Albany Molecular Research, Inc. | 40 |
1 |
| Anhui Medical University | 20 |
1 |
| Anhui New Star Pharmaceutical Development Co., Ltd. | 13 |
1 |
| Bioxell S.p.A. | 5 |
1 |
| The Board of Regents of the University of Oklahoma | 618 |
1 |
| Cabio Biotech (Wuhan) Co., Ltd. | 26 |
1 |
| Department of Biotechnology | 69 |
1 |
| The Government of the United States of America, as represented by the Secretary of the Navy | 1328 |
1 |
| National Brain Research Centre | 9 |
1 |
| National University Corporation Nara Institute of Science and Technology | 239 |
1 |
| OmniActive Health Technologies Limited | 113 |
1 |
| Revance Therapeutics, Inc. | 127 |
1 |
| Other owners | 5 |